Vanguard Group Inc Amphastar Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

  • $5.57 Trillion
  • Q4 2024

A detailed history of Vanguard Group Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,714,628 shares of AMPH stock, worth $85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,714,628
Previous 2,711,473 0.12%
Holding current value
$85 Million
Previous $132 Million 23.4%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$36.84 - $53.4 $116,230 - $168,477
3,155 Added 0.12%
2,714,628 $101 Million
Q3 2024

Nov 13, 2024
BUY
$36.99 - $50.09 $1.43 Million - $1.93 Million
38,611 Added 1.44%
2,711,473 $132 Million
Q2 2024

Aug 13, 2024
SELL
$38.65 - $43.48 $2.36 Million - $2.66 Million
-61,178 Reduced 2.24%
2,672,862 $107 Million
Q1 2024

May 10, 2024
SELL
$42.85 - $63.45 $3.49 Million - $5.17 Million
-81,556 Reduced 2.9%
2,734,040 $120 Million
Q4 2023

Feb 14, 2024
BUY
$44.49 - $62.93 $2.14 Million - $3.03 Million
48,203 Added 1.74%
2,815,596 $174 Million
Q3 2023

Nov 14, 2023
SELL
$45.51 - $65.0 $282,890 - $404,040
-6,216 Reduced 0.22%
2,767,393 $127 Million
Q2 2023

Aug 14, 2023
BUY
$35.77 - $58.38 $4.36 Million - $7.12 Million
122,004 Added 4.6%
2,773,609 $159 Million
Q1 2023

Jul 14, 2023
BUY
$27.99 - $37.92 $24,799 - $33,597
886 Added 0.03%
2,651,605 $99.4 Million
Q1 2023

May 15, 2023
BUY
$27.99 - $37.92 $809,246 - $1.1 Million
28,912 Added 1.1%
2,650,719 $99.4 Million
Q4 2022

Feb 10, 2023
BUY
$27.93 - $31.27 $436,964 - $489,219
15,645 Added 0.6%
2,621,807 $73.5 Million
Q3 2022

Nov 14, 2022
BUY
$27.56 - $37.75 $1.25 Million - $1.71 Million
45,385 Added 1.77%
2,606,162 $73.2 Million
Q2 2022

Aug 12, 2022
BUY
$29.79 - $42.29 $2.31 Million - $3.28 Million
77,572 Added 3.12%
2,560,777 $89.1 Million
Q1 2022

May 13, 2022
BUY
$22.96 - $36.45 $346,558 - $550,176
15,094 Added 0.61%
2,483,205 $89.1 Million
Q4 2021

Feb 14, 2022
SELL
$18.14 - $23.29 $988,865 - $1.27 Million
-54,513 Reduced 2.16%
2,468,111 $57.5 Million
Q3 2021

Nov 12, 2021
BUY
$17.83 - $21.49 $1.12 Million - $1.35 Million
62,893 Added 2.56%
2,522,624 $48 Million
Q2 2021

Aug 13, 2021
BUY
$17.11 - $20.92 $42.1 Million - $51.5 Million
2,459,731 New
2,459,731 $49.6 Million

Others Institutions Holding AMPH

# of Institutions
275
Shares Held
35.2M
Call Options Held
26.5K
Put Options Held
7.9K
View Full List

About Amphastar Pharmaceuticals, Inc.

AMPH Quotes by TradingView
  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.53B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email